This apparent contradiction may be explained by the autocrine mode of action of these cytokines following their production, implying that COVID-19 patients, especially those with severe disease, produce soluble IL-1ra and IL-33r (sST2) in an apparent effort to curtail the effect of IL-1β and IL-33, respectively. Here, IL33 is linked to COVID-19.